共 50 条
Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?
被引:11
|作者:
Sakcak, Ibrahim
[1
]
Yildiz, Baris Dogu
[1
]
Avsar, Fatih Mehmet
[1
]
Akturan, Saadet
[3
]
Kilic, Kemal
[2
]
Cosgun, Erdal
[4
]
Hamamci, Enver O.
[1
]
机构:
[1] Numune Teaching & Res Hosp, Dept Gen Surg 6, TR-06100 Ankara, Turkey
[2] Kafkas Univ, Fac Med, Dept Gen Surg, TR-36000 Kars, Turkey
[3] Etlik Teaching & Res Hosp, DeDepartment Gen Surg, TR-06010 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Stat, TR-06100 Ankara, Turkey
关键词:
Gastric cancer;
Lymph node dissection;
Node ratio;
Tumor nodule metastasis;
INDEPENDENT PROGNOSTIC-FACTOR;
STAGE MIGRATION;
RANDOMIZED TRIAL;
GASTRECTOMY;
RESECTION;
NUMBER;
LYMPHADENECTOMY;
CLASSIFICATION;
METASTASIS;
MORBIDITY;
D O I:
10.3748/wjg.v17.i35.4007
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
AIM: To identify whether there could have been changes in survival if lymph node ratio (N ratio) had been used. METHODS: We assessed 334 gastric adenocarcinoma cases retrospectively between 2001 and 2009. Two hundred and sixteen patients out of 334 were included in the study. Patients were grouped according to disection1 (D1) or dissection 2 (D2) dissection. We compared the estimated survival and actual survival determined by pathologic nodes (pN) class and N ratio, and SPSS 15.0 software was used for statistical analysis. RESULTS: Ninety-six (44.4%) patients underwent D1 dissection and 120 (55.6%) had D2 dissection. When groups were evaluated, 23 (24.0%) patients in D1 and 21 (17.5%) in D2 had stage migration (P = 0.001). When both D1 and D2 groups were evaluated for number of pathological lymph nodes, despite the fact that there was no difference in N ratio between D1 and D2 groups, a statistically significant difference was found between them with regard to pN1 and pN2 groups (P = 0.047, P = 0.044 respectively). In D1, pN0 had the longest survival while pN3 had the shortest. In D2, pN0 had the longest survival whereas pN3 had the shortest survival. CONCLUSION: N ratio is an accurate staging system for defining prognosis and treatment plan, thus decreasing methodological errors in gastric cancer staging. (c) 2011 Baishideng. All rights reserved.
引用
收藏
页码:4007 / 4012
页数:6
相关论文